01—Abstract
Summary
Summary of the 10-K/A filed June 25, 1996. Cited figures are marked; the original filing is the authoritative source.
The document you provided is not a Merck & Co. (MRK) 10-K annual report.
It is Amendment No. 2 to Schering-Plough Corporation's Form 10-K for the fiscal year ended December 31, 1995, filed June 24-25, 1996. Its sole purpose is to add the Form 11-K annual report for The Schering-Plough Puerto Rico Employees' Retirement Savings Plan, which Schering-Plough filed as Exhibit 28(b). The filing contains no information on Merck's business, revenues, earnings, or strategy, so it cannot support an investment analysis of MRK.
The plan is a defined contribution savings plan covering Puerto Rico employees of Schering-Plough Products, Inc. and Schering-Plough del Caribe, Inc. Net assets available for benefits rose 31% to $7,332,952a at December 31, 1995, from $5,587,441 a year earlier. Participants fell from 1,032 to 836, and the increase came mainly from $996,722 of net investment appreciation and $1,372,202 of participant contributions. Roughly 84% of plan assets were in Vanguard registered investment company shares, with the Vanguard Index 500 Portfolio the largest holding at $3.03 million.
Schering-Plough stock held in the plan was valued at $245,165,b or $247.68 per unit. The independent auditor, Deloitte & Touche LLP (San Juan), issued an unqualified opinion on the plan's financial statements.
The main investor-relevant item is that the 1995 sale of Schering-Plough's vision care division led to a $711,687c transfer of participant accounts to a successor savings plan. For a Merck analysis, you would need Merck's own 10-K for fiscal 1995 or 1996, which this document does not include.
02—Key points
Key Highlights
- Document identity: this is Schering-Plough Corporation's Form 10-K/A (Amendment No. 2) for FY1995, not a Merck & Co. (MRK) 10-K, and it was signed June 24, 1996.
- Purpose: the amendment adds the Form 11-K annual report for The Schering-Plough Puerto Rico Employees' Retirement Savings Plan, a defined contribution plan. It contains no corporate financial results for Merck or Schering-Plough.
- Plan size: net assets available for benefits grew 31% to $7,332,952 at December 31, 1995, from $5,587,441 in 1994.
- Plan income: 1995 additions totaled $2,758,225, including $1,372,202 in participant contributions and $1,386,023 in investment income and appreciation.
- Asset mix: about 84% of plan assets sat in Vanguard mutual funds, led by the Index 500 Portfolio ($3,025,474); Schering-Plough stock fund holdings were $245,165.
- Participation: participants declined to 836 from 1,032, and a 1995 divestiture (vision care division sale) moved $711,687 of accounts to a successor savings plan.
- Audit: Deloitte & Touche LLP issued an unqualified opinion on the plan's financial statements.
03—Questions
Frequently Asked Questions
Is this filing a Merck & Co. (MRK) 10-K annual report?
No. It is Schering-Plough Corporation's Form 10-K/A Amendment No. 2 for fiscal year 1995. It attaches a Form 11-K for a Puerto Rico employee savings plan and contains no Merck financial statements, business description, or risk factors.
What does this amendment actually disclose?
It discloses the financial statements and supplemental schedules of The Schering-Plough Puerto Rico Employees' Retirement Savings Plan for 1995 and 1994, prepared under ERISA reporting requirements and audited by Deloitte & Touche LLP.
How large is the plan and how did it change in 1995?
Net assets available for benefits were $7,332,952 at year-end 1995, up from $5,587,441 in 1994. The increase came from $1,745,511 in net additions after $1,012,714 in distributions to participants and to the successor savings plan. Participants fell from 1,032 to 836.
Why were participant accounts transferred out of the plan?
During 1995 Schering-Plough sold its vision care division to an unrelated third party. The buyer hired those employees and set up a new savings plan, and their accounts were moved there, which accounts for the $711,687 distribution to the successor plan.
Where can an MRK investor find the relevant information?
Merck & Co.'s own annual report on Form 10-K for fiscal 1995 or 1996, filed with the SEC, would contain the company's financial statements, business segments, and risk disclosures. This amendment does not provide them.
04—Continue